Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population
- PMID: 32765800
- PMCID: PMC7395404
- DOI: 10.1186/s13053-020-00147-w
Polymorphisms in MMP-1, MMP-2, MMP-7, MMP-13 and MT2A do not contribute to breast, lung and colon cancer risk in polish population
Abstract
Background: Matrix metalloproteinases (MMPs) and metallothioneins (MTs) are Zinc-related proteins which are involved in processes crucial for carcinogenesis such as angiogenesis, proliferation and apoptosis. Several single nucleotide polymorphisms (SNPs) in MMPs and MTs that affect genes expression have been associated with cancer risk, including breast, lung and colon.
Methods: The study group consisted of 648 unselected patients (299 with breast cancer, 199 with lung cancer, 150 with colon cancer) and 648 unaffected individuals. Five SNPs, rs1799750 in MMP-1, rs243865 in MMP-2, rs11568818 in MMP-7, rs2252070 in MMP-13 and rs28366003 in MT2A were genotyped and serum zinc (Zn) level was measured. The cancer risk was calculated using multivariable logistic regression with respect to Zn.
Results: None of the 5 tested polymorphisms showed a correlation with cancer risk in studied groups, although for MMP-2, MMP-7 and MT2A non-significant differences in genotypes frequencies among cases and controls were observed.
Conclusions: Analyses of polymorphisms, rs1799750 in MMP-1, rs243865 in MMP-2, rs11568818 in MMP-7, rs2252070 in MMP-13 and rs28366003 in MT2A in relation to serum Zn level did not show significant association with breast, lung and colon cancer risk among polish patients. Further studies are needed to verify this observation.
Keywords: Matrix metalloproteinases; Metallothioneins; Polymorphisms; Prostate cancer.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsJL is CEO of Read-Gene S.A. The authors WM, MM are employees of Read-Gene S.A. KB, PB, SG, KJB, GS, KD, TG, ML, KP, AŁ, CC, TH, JG, TD, AJ declare that they have no competing interests.
Similar articles
-
Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population.PLoS One. 2018 Jul 23;13(7):e0201065. doi: 10.1371/journal.pone.0201065. eCollection 2018. PLoS One. 2018. PMID: 30036379 Free PMC article.
-
Evaluation of matrix metalloproteinase-1, -2, -3, -7, and -13 gene polymorphisms in patients with chronic periodontitis and healthy controls.Clin Oral Investig. 2023 Dec;27(12):7417-7423. doi: 10.1007/s00784-023-05331-5. Epub 2023 Oct 17. Clin Oral Investig. 2023. PMID: 37848583
-
Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer.Clin Exp Med. 2014 Feb;14(1):107-13. doi: 10.1007/s10238-012-0215-4. Epub 2012 Oct 6. Clin Exp Med. 2014. PMID: 23053628 Free PMC article.
-
Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans.Arh Hig Rada Toksikol. 2020 Mar 1;71(1):27-47. doi: 10.2478/aiht-2020-71-3349. Arh Hig Rada Toksikol. 2020. PMID: 32597135 Free PMC article. Review.
-
Association of Matrix Metalloproteinase (MMP) Gene Polymorphisms With Knee Osteoarthritis: A Review of the Literature.Cureus. 2021 Oct 8;13(10):e18607. doi: 10.7759/cureus.18607. eCollection 2021 Oct. Cureus. 2021. PMID: 34765365 Free PMC article. Review.
Cited by
-
KLF4, a Key Regulator of a Transitive Triplet, Acts on the TGF-β Signaling Pathway and Contributes to High-Altitude Adaptation of Tibetan Pigs.Front Genet. 2021 Apr 15;12:628192. doi: 10.3389/fgene.2021.628192. eCollection 2021. Front Genet. 2021. PMID: 33936161 Free PMC article.
-
Matrix Metalloproteinase-7 Promoter Site Single Nucleotide Polymorphism (-181A>G) in Epithelial Ovarian Cancer in the Eastern Indian Population.Cureus. 2024 Mar 18;16(3):e56417. doi: 10.7759/cureus.56417. eCollection 2024 Mar. Cureus. 2024. PMID: 38638796 Free PMC article.
-
Association of MMP1 gene polymorphisms with breast cancer risk: A narrative review.Health Sci Rep. 2023 Oct 13;6(10):e1607. doi: 10.1002/hsr2.1607. eCollection 2023 Oct. Health Sci Rep. 2023. PMID: 37841939 Free PMC article.
-
Causal relationships between serum matrix metalloproteinases and estrogen receptor-negative breast cancer: a bidirectional mendelian randomization study.Sci Rep. 2023 May 15;13(1):7849. doi: 10.1038/s41598-023-34200-0. Sci Rep. 2023. PMID: 37188722 Free PMC article.
-
Matrix Metalloproteinase Gene Polymorphisms Are Associated with Breast Cancer in the Caucasian Women of Russia.Int J Mol Sci. 2022 Oct 20;23(20):12638. doi: 10.3390/ijms232012638. Int J Mol Sci. 2022. PMID: 36293492 Free PMC article.
References
-
- Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. J Enzyme Inhib Med Chem. 2016;31(sup1):177–183. - PubMed
-
- Lipka D, Boratyński J. Metalloproteinases. Structure and function. Postepy Hig Med Dosw. 2008;62:328–336. - PubMed
-
- Chabottaux V, Noel A. Breast cancer progression: insights into multifaceted matrix metalloproteinases. Clin Exp Metastasis. 2007;24(8):647–656. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous